126 related articles for article (PubMed ID: 10712566)
1. Tyramine-induced endogenous noradrenaline efflux from in situ cardiac sympathetic nerve ending in cats.
Takauchi Y; Yamazaki T; Akiyama T
Acta Physiol Scand; 2000 Feb; 168(2):287-93. PubMed ID: 10712566
[TBL] [Abstract][Full Text] [Related]
2. Dialysate dihydroxyphenylglycol as a window for in situ axoplasmic norepinephrine disposition.
Yamazaki T; Akiyama T; Kitagwa H; Kawada T; Sunagawa K
Neurochem Int; 2001 Mar; 38(3):287-92. PubMed ID: 11099788
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ouabain-induced noradrenaline and acetylcholine release from in situ cardiac autonomic nerve endings.
Yamazaki T; Akiyama T; Kitagawa H; Komaki F; Mori H; Kawada T; Sunagawa K; Sugimachi M
Acta Physiol (Oxf); 2007 Dec; 191(4):275-84. PubMed ID: 17995575
[TBL] [Abstract][Full Text] [Related]
4. A new, concise dialysis approach to assessment of cardiac sympathetic nerve terminal abnormalities.
Yamazaki T; Akiyama T; Kitagawa H; Takauchi Y; Kawada T; Sunagawa K
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1182-7. PubMed ID: 9087591
[TBL] [Abstract][Full Text] [Related]
5. Effects of ouabain on in situ cardiac sympathetic nerve endings.
Yamazaki T; Akiyama T; Kawada T
Neurochem Int; 1999 Dec; 35(6):439-45. PubMed ID: 10524711
[TBL] [Abstract][Full Text] [Related]
6. In vivo monitoring of norepinephrine and its metabolites in skeletal muscle.
Tokunaga N; Yamazaki T; Akiyama T; Sano S; Mori H
Neurochem Int; 2003 Nov; 43(6):573-80. PubMed ID: 12820986
[TBL] [Abstract][Full Text] [Related]
7. Effects of moderate hypothermia on norepinephrine release evoked by ouabain, tyramine and cyanide.
Kitagawa H; Yamazaki T; Akiyama T; Mori H; Sunagawa K
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S111-4. PubMed ID: 12688406
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine efflux evoked by potassium chloride in cat sympathetic nerves: dual mechanism of action.
Yamazaki T; Akiyama T; Kawada T; Kitagawa H; Takauchi Y; Yahagi N; Sunagawa K
Brain Res; 1998 May; 794(1):146-50. PubMed ID: 9630583
[TBL] [Abstract][Full Text] [Related]
9. Effects of omega-conotoxin GVIA on cardiac sympathetic nerve function.
Yahagi N; Akiyama T; Yamazaki T
J Auton Nerv Syst; 1998 Jan; 68(1-2):43-8. PubMed ID: 9531444
[TBL] [Abstract][Full Text] [Related]
10. Effects of moderate hypothermia on in situ cardiac sympathetic nerve endings.
Kitagawa H; Akiyama T; Yamazaki T
Neurochem Int; 2002 Mar; 40(3):235-42. PubMed ID: 11741006
[TBL] [Abstract][Full Text] [Related]
11. Effects of ketamine on in vivo cardiac sympathetic nerve endings.
Kitagawa H; Yamazaki T; Akiyama T; Mori H; Sunagawa K
J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S39-42. PubMed ID: 11811357
[TBL] [Abstract][Full Text] [Related]
12. Possible mechanism of acetaldehyde-induced noradrenaline release from sympathetic nerve terminals in isolated blood vessels.
Chiba S; Tsukada M
Br J Pharmacol; 1988 Sep; 95(1):177-82. PubMed ID: 2905902
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria.
Paton DM
Br J Pharmacol; 1973 Dec; 49(4):614-27. PubMed ID: 4788035
[TBL] [Abstract][Full Text] [Related]
14. Norepinephrine and dihydroxyphenylglycol effluxes from sympathetic nerve endings during hypoxia and reoxygenation in the isolated rat heart.
Chahine R; Nadeau R; Lamontagne D; Yamaguchi N; de Champlain J
Can J Physiol Pharmacol; 1994 Jun; 72(6):595-601. PubMed ID: 7954091
[TBL] [Abstract][Full Text] [Related]
15. Effects of ketamine on exocytotic and non-exocytotic noradrenaline release.
Kitagawa H; Yamazaki T; Akiyama T; Mori H; Sunagawa K
Neurochem Int; 2003 Feb; 42(3):261-7. PubMed ID: 12427480
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.
Langeloh A; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):611-20. PubMed ID: 3444478
[TBL] [Abstract][Full Text] [Related]
17. Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.
Kurz T; Richardt G; Seyfarth M; Schömig A
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):7-16. PubMed ID: 8832582
[TBL] [Abstract][Full Text] [Related]
18. Extracellular sodium and chloride depletion enhances nonexocytotic noradrenaline release induced by energy deficiency in rat heart.
Kurz T; Schömig A
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):265-9. PubMed ID: 2812038
[TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of endogenous noradrenaline release in rat brain slices using fast cyclic voltammetry: 1. Characterisation of evoked noradrenaline efflux and uptake from nerve terminals in the bed nucleus of stria terminalis, pars ventralis.
Palij P; Stamford JA
Brain Res; 1992 Jul; 587(1):137-46. PubMed ID: 1525644
[TBL] [Abstract][Full Text] [Related]
20. In vitro release of [3H]noradrenaline by tyramine from the superior cervical ganglion and in the nictitating membrane of the cat.
Filinger EJ
Gen Pharmacol; 1994 Sep; 25(5):1045-9. PubMed ID: 7835623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
